Erdem Çubukçu - Concepedia

Author

Erdem Çubukçu

Also Known As

Cubukcu Erdem, E Cubukcu, E. Cubukcu, E. Çubukçu, Erdem Cubukcu, Erdem ubuku, Erdem ÇUBUKÇU, Erdem Çubukçu, Erdem çubukçu, Çubukçu, Erdem

137

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Bursa Uludağ Üni̇versi̇tesi̇Marmara University Acıbadem University Afyon Kocatepe University Gaziantep University

EÇ

About

Erdem Çubukçu is an author at Bursa Uludağ Üni̇versi̇tesi̇ specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	118
2	Health Sciences	1	1	39
3	Public Health	1	1	14
4	Clinical Nutrition	1	1	39
5	Immunology	1	1	25

Erdem Çubukçu

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer David Miles, Joseph Gligorov, Fabrice André, Annals of Oncology	2021	689
Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy Ahmet Bilgehan Şahin, Erdem Çubukçu, Birol Ocak, Scientific Reports	2021	113
Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis. Yalcin Cirak, Yavuz Furuncuoğlu, Asude Aksu, PubMed	2016	53
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? Arife Ulaş, Fahriye Tuğba Köş, Erdem Çubukçu, PubMed	2015	49
Medication Errors in Chemotherapy Preparation and Administration: a Survey Conducted among Oncology Nurses in Turkey Arife Ulaş, Didem Şener Dede, Muhammed Bülent Akıncı, Asian Pacific Journal of Cancer Prevention	2015	45
Comparison of Three Different Treatment Modalities in the Management of Cancer Cachexia Özkan Kanat, Erdem Çubukçu, Ferah Budak, Tumori Journal NutritionChemoprevention StrategyCancer ManagementSurgeryPharmacotherapy	2013	39
Comparison of three different treatment modalities in the management of cancer cachexia. Özkan Kanat, Erdem Çubukçu, Ferah Budak, PubMed	2013	29
The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme Ömer Fatih Ölmez, Erdem Çubukçu, Türkkan Evrensel, Clinical & Translational Oncology Neuro-oncologyTumor InnervationGlioblastoma MultiformeMalignant DiseaseMedicine	2013	25
Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer Muharrem Bayrak, Ömer Fatih Ölmez, Ender Kurt, Clinical & Translational Oncology Gastrointestinal OncologyMedicinePathologyCancer GenomicsPrognostic Significance	2012	22
Primary small cell carcinoma of the breast: report of seven cases and review of the literature. Özkan Kanat, Saadetin Kilickap, Taner Korkmaz, PubMed	2012	21

Page 1